These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 153421)

  • 1. [High molecular weight substances which inhibit calcium oxalate crystal growth. 4: Studies on the role of urinary pepsinogen and mucopolysaccharide as inhibitors of calcium oxalate crystal growth (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1355-9. PubMed ID: 153421
    [No Abstract]   [Full Text] [Related]  

  • 2. [High molecular weight substances which inhibit calcium oxalate crystal growth, 3: Studies on the characteristics of high molecular weight substances which inhibit calcium oxalate crystal growth (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1349-54. PubMed ID: 732069
    [No Abstract]   [Full Text] [Related]  

  • 3. [High molecular weight substances which inhibit calcium oxalate crystal growth. 1: Relative potencies of various kinds of urinary inhibitors which were determined new assay method (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1334-41. PubMed ID: 215812
    [No Abstract]   [Full Text] [Related]  

  • 4. [High molecular weight substances which inhibit calcium oxalate crystal growth. 2: Isolation and identification of a calcium oxalate crystal growth inhibitor from rat liver (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1342-8. PubMed ID: 732068
    [No Abstract]   [Full Text] [Related]  

  • 5. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    Trans Am Assoc Genitourin Surg; 1979; 71():62-6. PubMed ID: 161827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary low molecular promoter of calcium oxalate monohydrate crystal aggregation, preliminary report].
    Shirane Y; Hiraishi K; Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1149-54. PubMed ID: 3682505
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.
    Fellström B; Lindsjö M; Danielson BG; Karlsson FA; Ljunghall S
    Clin Chim Acta; 1989 Apr; 180(3):213-220. PubMed ID: 2472910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth of calcium oxalate crystals in vitro: a simple method for measurement of the inhibitory action of human urine (author's transl)].
    Hess B; Binswanger U
    J Clin Chem Clin Biochem; 1981 May; 19(5):295-9. PubMed ID: 7264571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans.
    Grover PK; Ryall RL; Marshall VR
    Kidney Int; 1992 Jan; 41(1):149-54. PubMed ID: 1593851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.